Skip to content

Upper Cross Syndrome and Neck Proprioception

Correlation Between Upper Cross Syndrome and Neck Proprioception

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06801613
Enrollment
80
Registered
2025-01-30
Start date
2025-05-31
Completion date
2025-10-25
Last updated
2025-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Cross Syndrome

Keywords

proprioception, upper cross syndrome, neck

Brief summary

Correlation Between Upper Cross Syndrome and Neck Proprioception Hypothesis: No statistically significant relationship exists between upper cross syndrome and neck proprioception. Study Design: Randomized Controlled Trial Participants: Office workers (≥4h computer use/day) Age: 28-48 years Chronic nonspecific neck pain (\>3 months) Forward head posture (FHP) \<46° VAS score: 3-8 cm No cognitive impairments affecting participation Exclusion Criteria: Systemic, rheumatic, or neuromuscular diseases Neurological signs, spinal surgery, or recent physical therapy Missing ≥3 consecutive or 4 nonconsecutive sessions

Detailed description

Study Title:Correlation Between Upper Cross Syndrome and Neck Proprioception Hypothesis:There will be no statistically significant relationship between upper cross syndrome and neck proprioception. Methodology: Study Design:Randomized controlled trial Inclusion Criteria: Office workers using a computer for at least 4 hours daily Aged between 28 and 48 years Neck pain (NP) between 3 and 8 cm on a visual analog scale (VAS) (0 = no pain, 10 = unbearable pain) Chronic nonspecific neck pain lasting for more than 3 months Forward head posture (FHP) less than 46° Patients willing and able to participate in an exercise program safely without cognitive impairments that would limit participation Exclusion Criteria: Specific causes of NP (e.g., systemic, rheumatic, neuromuscular diseases) Central or peripheral neurological signs Cognitive impairment History of spinal surgery Physical therapy treatments in the last 6 months prior to baseline assessment Participants missing at least three consecutive or four nonconsecutive sessions Outcome Measures: Spinal Curvature Assessment Using Spinal Mouse DeviceThe spinal mouse device is physically guided along the skin of the spine Neck Pain MeasurementNP is evaluated using a 10-cm VAS, a widely used clinical tool for assessing pain treatment effectiveness. Neck Disability Index (NDI)Disability is assessed using the NDI questionnaire. Measurement of Cervical Range of Motion (CROM) Using a CROM Assessment of Cervical Proprioception Using the CROM DeviceHead Reposition Accuracy Tests: Neutral Head Position (NHP) Test: Measures the ability to actively reposition the head to the self-selected neutral position. Target Head Position (THP) Test: Measures the ability to actively reposition the head to a previously demonstrated target position.

Interventions

OTHERIntervention Group

Group/Cohort Description: Participants with Upper Cross Syndrome (UCS) who undergo the prescribed exercise or treatment protocol.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
28 Years to 48 Years
Healthy volunteers
No

Inclusion criteria

* office workers (using a computer at least 4 h), * aged between 28 and 48 years, * NP between 3 and 8 cm on a visual analog scale (VAS) (from 0 indicating no pain at all to 10 indicating unbearable pain), * chronic nonspecific neck pain lasting for more than 3 months, and FHP less than 46° (Fathollahnejad et al., 2019). * Patients willing and able to participate in an exercise program safely and without cognitive impairments that would limit their participation.

Exclusion criteria

* specific causes of NP (e.g., systemic, rheumatic, neuromuscular diseases), central or peripheral neurological signs, cognitive impairment, spinal surgery, or physical therapy treatments in the last 6 months prior to the baseline assessment. * Participants would be also excluded if they missed at least three consecutive or four nonconsecutive sessions (Fathollahnejad et al., 2019).

Design outcomes

Primary

MeasureTime frameDescription
Cervical Proprioception:8 weeksMeasurement Tool: CROM device. Tests: Neutral Head Position (NHP): Assesses participants' ability to actively reposition their head to a self-selected neutral position. Target Head Position (THP): Assesses ability to reposition the head to a previously demonstrated target position.

Secondary

MeasureTime frameDescription
Neck Pain8 weeksMeasurement Tool: Visual Analog Scale (10-cm scale) Purpose: Evaluate participants' subjective pain levels before and after the intervention. Scale Range: 0 (no pain) to 10 (unbearable pain). Interpretation: Higher scores indicate worse pain levels.
Balance8 weeksMeasurement Tool: Biodex Balance System. Parameters: Static and dynamic balance. Postural stability score (lower scores indicate better balance). Purpose: Explore the effect of UCS on overall balance and stability.
Neck Disability Index (NDI):8 weeksMeasurement Tool: NDI questionnaire. Purpose: Assess the impact of neck pain on daily activities and functional limitations.
Cervical Range of Motion (CROM)8 weeksMeasurement Tool: CROM device. Purpose: Measure the range of motion in the cervical spine to detect restrictions due to UCS.

Other

MeasureTime frameDescription
Spinal Curvature:8 weeksMeasurement Tool: Spinal Mouse Device. Parameters: Sagittal plane alignment in neutral, flexion, and extension. Purpose: Assess structural changes or adaptations in the spine due to UCS.

Contacts

Primary ContactElsayed
omniaomniamohamed259@gmail.com+20 100 219 5353

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026